Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Avalon nominates lead clinical development candidate AVN-316

June 27, 2008

GPC Biotech initiates phase II trial of satraplatin in combination with prednisone in HRPC

June 27, 2008

Kinesin spindle protein inhibitor AZD-4877 evaluated in phase I studies at AstraZeneca

June 27, 2008

Pierre Fabre reports phase I results for omtriptolide in acute leukemias

June 27, 2008

MethylGene commences phase II MGCD-0103 trial in combination with Vidaza

June 27, 2008

PF-03814735 doses, tolerability explored in solid tumor patients

June 27, 2008

CuraGen commences phase II CR011-vcMMAE trial in advanced breast cancer

June 26, 2008

Elacyt gets orphan drug designation in U.S.

June 26, 2008

Mechanism-based target modulation evidenced with SNS-032 treatment

June 26, 2008

EMEA grants orphan drug status to Lorus Therapeutics' LOR-2040 in AML

June 25, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...